Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02529605 · ClinicalTrials.gov registry record · NA
Relative Bioavailability of Two Different Milk Thistle Formulations
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02529605 is a NA study that has completed, run by University of Florida. The registered enrollment target is 12 participants.
The verdict
NCT02529605, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a single dose, randomized, cross-over pharmacokinetic study in healthy volunteers (n=12) of two dietary supplement formulations. The Product B® IsaGenesis® formulation represents a newer reformulation of an existing product known simply as IsaGenesis®. Beyond some changes in the relative abundance of some of the constituents of the earlier IsaGenesis® formulation, the Product B® IsaGenesis® product has been formulated as a liquid-gel formulation (rather than a dried powder extract) which is theorized to enhance the absorption and bioavailability of the contained botanical constituents. The purpose of this study is to compare the two dietary supplement formulations relative to the absorption of two compounds contained within the supplement known as the flavonolignans silybin A and silybin B into the bloodstream after oral administration of capsules.
Interventions
- DIETARY_SUPPLEMENT Product B® IsaGenesis®
- DIETARY_SUPPLEMENT IsaGenesis®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02529605
The ClinicalTrials.gov registry entry for NCT02529605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Product B® IsaGenesis® is the first listed.
NCT02529605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02529605 about?
NCT02529605 is a clinical study titled "Relative Bioavailability of Two Different Milk Thistle Formulations". This is a single dose, randomized, cross-over pharmacokinetic study in healthy volunteers (n=12) of two dietary supplement formulations. The Product B® IsaGenesis® formulation represents a newer reformulation of an existing product known simply as IsaGenesis®. Beyond some changes in the relative abu...
What is the current status of trial NCT02529605?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-09. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02529605?
The interventions under investigation include: Product B® IsaGenesis® (DIETARY_SUPPLEMENT), IsaGenesis® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02529605?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.